Amit Sharma^1*, Pallavi Sharma², Rashmi Sharma³

¹CMO, IIIM Jammu, Jammu and Kashmir, INDIA.

{²Senior Resident, Department of Ophthalmology} {³Senior Resident, Department of Pharmacology} Government Medical College, Jammu, Jammu and Kashmir, INDIA.

Email: amitmedicinerrl@gmail.com

REFERENCES

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 2002; 51: 1-16.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002; 47: 1184-99.
3. Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5: 93-9.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349: 1436-42.
5. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130: 993–998.
6. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166: 314–322.
7. T. M. Kolb and P. M. Hassoun, “Right ventricular dysfunction in chronic lung disease,” Cardiology Clinics, vol. 30, no. 2, pp. 243–256, 2012.
8. X. Freixa, K. Portillo, C. Par´e et al., “Echocardiographic abnormalities in patients withCOPDat their first hospital admission,” European Respiratory Journal, vol. 41, no. 4, pp. 784–791, 2013.
9. J. P.Wrobel, B. R. Thompson, and T. J.Williams, “Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review,” Journal of Heart and Lung Transplantation, vol. 31, no. 6, pp. 557–564, 2012.
10. H. D. Poor, R. Girgis, and S. M. Studer, “World Health Organization Group III pulmonary hypertension,” Progress in Cardiovascular Diseases, vol. 55, no. 2, pp. 119–127, 2012.
11. N. Sommer, A. Dietrich, R. T. Schermuly et al., “Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms,” European Respiratory Journal, vol. 32,no. 6, pp. 1639–1651, 2008.
12. Padity E, et al. ECHO diagnosis of pulmonary hypertension in chronic lung diseases. Phrenology 1992; 46: 131-140.
13. Schiller NB, Shah P,. Et al. Recommendations for quantization of left ventricle by two dimensional echocardiography. American Society of Echocardiography. J Am Soc Echocardiography 1989; 2: 358-367.
14. Karyenbuehl HP et al. The effect of hypertrophy on diastolic mechanics of left ventricle during chronic pressure overload. Circulation 1978; 57(supp‖):‖-158.
15. Lazar JM, et al. Effects of chronic right ventricular pressure overload on left ventricular diastolic functions. Am, J Cardiol 1993; 72: 1179-1182.
16. Marcus JT, et al. Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension. Chest 2001; 19: 1761-1765.
17. Steele P, et al. Left ventricular functions in patients of COAD. N Eng J Med 1974; 9: 1-7.
18. Tutar, et al. ECHO features of primary pulmonary hypertension. J Am Soc Echocardiography 1999;12:655-662.
19. Moustapha A, et al. Echocardiographic evaluation of left ventricular diastolic function in patients with chronic pulmonary hypertension. Cardiology 2001:3:50-54.
20. Johnson GL, et al. Changes in left ventricular diastolic filling patterns by Doppler ECHO in cystic fibrosis. Chest 1991; 99:646-650.
21. Schema M, et al. Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest 1996; 09: 1446-1451.